HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Yamaoka Selected Research

Microsatellite Instability

10/2020Complete response to pembrolizumab in advanced hepatocellular carcinoma with microsatellite instability.
7/2020Incidence of microsatellite instability-high hepatocellular carcinoma among Japanese patients and response to pembrolizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Yamaoka Research Topics

Disease

17Hepatocellular Carcinoma (Hepatoma)
03/2024 - 01/2020
9Neoplasms (Cancer)
11/2023 - 01/2020
3Neoplasm Metastasis (Metastasis)
11/2023 - 01/2021
3Liver Diseases (Liver Disease)
01/2023 - 10/2020
3Thrombosis (Thrombus)
10/2021 - 10/2020
2Pain (Aches)
11/2023 - 01/2018
2Microsatellite Instability
10/2020 - 07/2020
1Portal Hypertension
03/2024
1Overweight
02/2024
1Liver Cirrhosis (Hepatic Cirrhosis)
02/2024
1Anorexia
11/2023
1Fatigue
11/2023
1Hypertension (High Blood Pressure)
11/2023
1Proteinuria
11/2023
1Inflammation (Inflammations)
01/2023
1Body Weight (Weight, Body)
01/2023
1Fibrosis (Cirrhosis)
01/2023
1Non-alcoholic Fatty Liver Disease
01/2023
1Weight Loss (Weight Reduction)
01/2023
1Type 2 Diabetes Mellitus (MODY)
01/2023
1Sclerosing Cholangitis
02/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2021
1Lung Neoplasms (Lung Cancer)
02/2021
1Liver Failure
02/2021
1Necrosis
01/2021
1Disease Progression
01/2020

Drug/Important Bio-Agent (IBA)

9lenvatinibIBA
11/2023 - 01/2020
6atezolizumabIBA
03/2024 - 10/2021
6Bevacizumab (Avastin)FDA Link
03/2024 - 10/2021
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
02/2024 - 01/2020
3Sorafenib (BAY 43-9006)FDA Link
09/2023 - 10/2020
2Immune Checkpoint InhibitorsIBA
02/2021 - 10/2020
2pembrolizumabIBA
10/2020 - 07/2020
1collagen type I trimeric cross-linked peptideIBA
11/2023
1Collagen Type I (Type I Collagen)IBA
11/2023
1Zoledronic Acid (Zometa)FDA Link
11/2023
1DenosumabFDA Link
11/2023
1Blood Glucose (Blood Sugar)IBA
01/2023
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2023
1LipidsIBA
01/2023
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2023
1Glucose (Dextrose)FDA LinkGeneric
01/2023
1Hemoglobins (Hemoglobin)IBA
01/2023
1Alanine Transaminase (SGPT)IBA
01/2023
1SodiumIBA
01/2023
1Uric Acid (Urate)IBA
01/2023
1Therapeutic UsesIBA
01/2023
1Cisplatin (Platino)FDA LinkGeneric
06/2022
1Prednisolone (Predate)FDA LinkGeneric
02/2021
1NivolumabIBA
02/2021
1EnzymesIBA
02/2021
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
02/2021
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
02/2021
1AntigensIBA
01/2021
1regorafenibIBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2018
1Analgesics (Analgesic Drugs)IBA
01/2018

Therapy/Procedure

12Therapeutics
03/2024 - 01/2020
4Radiotherapy
01/2023 - 10/2020
4Drug Therapy (Chemotherapy)
06/2022 - 10/2020
1Activities of Daily Living (ADL)
11/2023
1Fluid Therapy (Oral Rehydration Therapy)
10/2021
1Stents
10/2021